The anticoagulant blood-thinning drug Xarelto, which is manufactured by Bayer AG and is marketed in the United States by the Johnson & Johnson subsidiary Janssen Pharmaceutical, was approved by The U....
S. Food and Drug Administration in 2011. Since it became available and its approved usage has expanded, there have been an increasing amount of reports that Xarelto increases the risks of internal bleeding and other serious side effects.
Thank you for subscribing to the Visually newsletter.
Just one last thing: we've sent you an email asking you to confirm your subscription.
Tell your story visually before December 31st and get a free iPad Air!*
The holidays are a great time to tell your brand story. From Black Friday trends and Mobile Shopping guides to the Best and Worst Times to Book Travel and Thanksgiving etiquette, the Visually team will help you craft your brand's unique stories and raise your social profile during the noisy holiday season.
*Requires $10k minimum purchase
Accepted formats : JPG, JPEG, GIF, PNG, PDF
Select the type of visual content you want to share